ADMA Biologics (ADMA) rose 15% after refuting claims from a Culper Research short report. "ADMA believes that by providing, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results